Subscribe To
Biopharma firm gilead picks amazon as cloud provider
Biopharmaceutical company Gilead Sciences has chosen Amazon Web Services as its cloud provider, AWS announced Monday (Nov. 29). “Innovating on AWS a...
November 29, 2021, 1:24 pm
Biopharma firm gilead picks amazon as cloud provider
Biopharmaceutical company Gilead Sciences has chosen Amazon Web Services as its cloud provider, AWS announced Monday (Nov. 29). “Innovating on AWS a...
November 29, 2021, 1:24 pm
Ground-breaking clinical data from insight trial presented at viva
Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avi...
October 7, 2021, 8:45 am
Ground-breaking clinical data from insight trial presented at viva
Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avi...
October 7, 2021, 8:45 am
Ground-breaking clinical data from insight trial presented at viva
Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avi...
October 7, 2021, 8:45 am
Rexlemestrocel-l phase 3 trial results in chronic heart failure selected as late breaking presentation at american heart association annual meeting
NEW YORK, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...
October 6, 2021, 8:38 pm
Rexlemestrocel-l phase 3 trial results in chronic heart failure selected as late breaking presentation at american heart association annual meeting
NEW YORK, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...
October 6, 2021, 8:38 pm
Rexlemestrocel-l phase 3 trial results in chronic heart failure selected as late breaking presentation at american heart association annual meeting
NEW YORK, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...
October 6, 2021, 8:38 pm
Boston scientific's eluvia drug-eluting vascular stent tops bare metal stents
Boston Scientific Corporation (NYSE: BSX) has announced data for the Eluvia Drug-Eluting Vascular Stent System (Eluvia stent) at the Vascular Inter...
October 6, 2021, 3:38 pm
Boston scientific's eluvia drug-eluting vascular stent tops bare metal stents
Boston Scientific Corporation (NYSE: BSX) has announced data for the Eluvia Drug-Eluting Vascular Stent System (Eluvia stent) at the Vascular Inter...
October 6, 2021, 3:38 pm
Boston scientific's eluvia drug-eluting vascular stent tops bare metal stents
Boston Scientific Corporation (NYSE: BSX) has announced data for the Eluvia Drug-Eluting Vascular Stent System (Eluvia stent) at the Vascular Inter...
October 6, 2021, 3:38 pm
Boston scientific eluvia™ drug-eluting vascular stent system exhibits superiority compared to bare metal stents
LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ -- Today, Boston Scientific Corporation (NYSE: BSX) announced positive data for the Eluvia...
October 6, 2021, 12:35 pm
Boston scientific eluvia™ drug-eluting vascular stent system exhibits superiority compared to bare metal stents
LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ -- Today, Boston Scientific Corporation (NYSE: BSX) announced positive data for the Eluvia...
October 6, 2021, 12:35 pm
Boston scientific eluvia™ drug-eluting vascular stent system exhibits superiority compared to bare metal stents
LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ -- Today, Boston Scientific Corporation (NYSE: BSX) announced positive data for the Eluvia...
October 6, 2021, 12:35 pm
Boston scientific highlights trial data for ekosonic system for pulmonary embolism
Boston Scientific Corporation (NYSE: BSX) announced results for the EkoSonic Endovascular System at the Vascular InterVentional ...
October 6, 2021, 7:15 am
Boston scientific highlights trial data for ekosonic system for pulmonary embolism
Boston Scientific Corporation (NYSE: BSX) announced results for the EkoSonic Endovascular System at the Vascular InterVentional ...
October 6, 2021, 7:15 am
Boston scientific highlights trial data for ekosonic system for pulmonary embolism
Boston Scientific Corporation (NYSE: BSX) announced results for the EkoSonic Endovascular System at the Vascular InterVentional ...
October 6, 2021, 7:15 am
Positive late-breaking clinical trial data for the ekosonic™ endovascular system presented at viva21
LAS VEGAS and MARLBOROUGH, Mass., Oct. 5, 2021 /PRNewswire/ -- Today, Boston Scientific (NYSE: BSX) announced positive results for the EkoSonic™ En...
October 5, 2021, 4:21 pm
Positive late-breaking clinical trial data for the ekosonic™ endovascular system presented at viva21
LAS VEGAS and MARLBOROUGH, Mass., Oct. 5, 2021 /PRNewswire/ -- Today, Boston Scientific (NYSE: BSX) announced positive results for the EkoSonic™ En...
October 5, 2021, 4:21 pm
Positive late-breaking clinical trial data for the ekosonic™ endovascular system presented at viva21
LAS VEGAS and MARLBOROUGH, Mass., Oct. 5, 2021 /PRNewswire/ -- Today, Boston Scientific (NYSE: BSX) announced positive results for the EkoSonic™ En...
October 5, 2021, 4:21 pm